These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs? Senchak J; Ahr K; von Mehren M Curr Treat Options Oncol; 2022 May; 23(5):749-761. PubMed ID: 35349049 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data. von Mehren M; Heinrich MC; Shi H; Iannazzo S; Mankoski R; Dimitrijević S; Hoehn G; Chiroli S; George S BMC Cancer; 2021 Mar; 21(1):291. PubMed ID: 33740926 [TBL] [Abstract][Full Text] [Related]
6. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib. Mohammadi M; Gelderblom H Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274 [No Abstract] [Full Text] [Related]
7. Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor. Bauer S; George S; von Mehren M; Heinrich MC Front Oncol; 2021; 11():672500. PubMed ID: 34322383 [TBL] [Abstract][Full Text] [Related]
8. Combination of Type I and II tyrosine kinase inhibitors-avapritinib and sunitinib-in refractory gastrointestinal stromal tumor after failure to multi-line therapy: a case report. Guo X; Huang S; Shi Y; Guan Z; Chen S; Feng Y; Xia Y; Zhang X Ann Transl Med; 2022 Sep; 10(18):1026. PubMed ID: 36267752 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation]. Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512 [No Abstract] [Full Text] [Related]
10. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. Golčić M; Jones RL; Huang P; Napolitano A Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627109 [TBL] [Abstract][Full Text] [Related]
11. Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors. Gebreyohannes YK; Wozniak A; Zhai ME; Wellens J; Cornillie J; Vanleeuw U; Evans E; Gardino AK; Lengauer C; Debiec-Rychter M; Sciot R; Schöffski P Clin Cancer Res; 2019 Jan; 25(2):609-618. PubMed ID: 30274985 [TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management]. Reichardt P; Reichardt A Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513 [TBL] [Abstract][Full Text] [Related]
13. Fourth-line rescue treatment ripretinib of advanced small intestine gastrointestinal stromal tumors who achieved partial response: a case report. Liu B; Kou Y J Gastrointest Oncol; 2022 Jun; 13(3):1505-1513. PubMed ID: 35837161 [TBL] [Abstract][Full Text] [Related]
14. Precision medicine in gastrointestinal stromal tumors. Florou V; Trent JC; Wilky BA Discov Med; 2019; 28(155):267-276. PubMed ID: 32053767 [TBL] [Abstract][Full Text] [Related]
15. New frontiers in the medical management of gastrointestinal stromal tumours. Mazzocca A; Napolitano A; Silletta M; Spalato Ceruso M; Santini D; Tonini G; Vincenzi B Ther Adv Med Oncol; 2019; 11():1758835919841946. PubMed ID: 31205499 [TBL] [Abstract][Full Text] [Related]
16. Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward. Lostes-Bardaji MJ; García-Illescas D; Valverde C; Serrano C Ther Adv Med Oncol; 2021; 13():1758835920986498. PubMed ID: 33473249 [TBL] [Abstract][Full Text] [Related]
17. Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors. Smrke A; Gennatas S; Huang P; Jones RL Future Oncol; 2020 Aug; 16(22):1639-1646. PubMed ID: 32517495 [TBL] [Abstract][Full Text] [Related]
18. Progression of the tumor in a patient with a gastrointestinal stromal tumor with the An Z; Tan M; Xia Y; Li Y; Fan L; Zhao Q; Zhang Z; Tan B; Liu Y; Ma Z; Wang D; Zhao X J Gastrointest Oncol; 2022 Oct; 13(5):2620-2625. PubMed ID: 36388657 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Landi B; Blay JY; Bonvalot S; Brasseur M; Coindre JM; Emile JF; Hautefeuille V; Honore C; Lartigau E; Mantion G; Pracht M; Le Cesne A; Ducreux M; Bouche O; ; ; ; ; ; ; Dig Liver Dis; 2019 Sep; 51(9):1223-1231. PubMed ID: 31387778 [TBL] [Abstract][Full Text] [Related]